CORONAVIRUS VACCINE
Coronavirus Vaccine Update: China's Sinovac Biotech 90% Successful in Phase I and II Trials, Final Tests in Brazil
Coronavirus Vaccine: AstraZeneca Awarded Deal to Supply Europe With 400 Million Doses by 2020-End
Coronavirus Vaccine: Study on Mouse Finds Moderna Doses to be Effective With No Major Side-Effects
COVID-19 Vaccine: As Per Moderna Estimate, Less Than 13% of Global Population Can be Vaccinated by 2021-End
Coronavirus Antibody Treatment: AstraZeneca Nearing Breakthrough on 'Life-Saving' Therapy for Elderly and Vulnerable Patients
COVID-19 Vaccine: US-Based Moderna Begins Phase 2 Human Trials for Coronavirus Vaccine
Coronavirus Vaccine Update: From Ayurveda to Remdesivir And More, Here's What Progress India, US, China And Other Countries Have Made so Far
COVID-19 Vaccine Race: China's Sinovac Sure of '99% Success', Targets Release by 2020-End; Moderna Begins 2nd Phase of Clinical Trials
COVID-19 Vaccine Likely in 2020, but Production Only by 2021-End, Says Swedish Physician Dr Anders Tegnell
Rahul Gandhi Talk Show: Congress MP Asks Renowned Health Professionals on Deadline of Coronavirus Vaccine, Professor Ashish Jha Says 'Wait Until Next Year'
COVID-19 FAQs Answered: Coronavirus Count in the World, Total Deaths Due to COVID-19 and More
Novavax, US Biotechnology Company, Begins Trials Coronavirus Vaccine Candidate in Australia
Oxford University Says Coronavirus Vaccine 'Progressing Very Well', Will Expand Trial to Older Adults and Children
AstraZeneca Receives $1 Billion From US to Develop a Coronavirus Vaccine, Production and Delivery from the University of Oxford
Google Trends